PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-ll Study

aTyr Reports Results of ATYR1923 in P-ll Study for COVID-19 Patients with Severe Respiratory Complications

aTyr Reports Results of ATYR1923 in P-ll Study for COVID-19 Patients with Severe Respiratory Complications

January 5, 2021

AstraZenca's Calquence (acalabrutinib) Fails to Meet its Primary Endpoint in P-II Studies for COVID-19

AstraZenca's Calquence (acalabrutinib) Fails to Meet its Primary Endpoint in P-II Studies for COVID-19

November 12, 2020

Novartis Presents Results of Iptacopan (LNP023) in P-ll Study for C3 Glomerulopathy at ASN Annual Meeting 2020

Novartis Presents Results of Iptacopan (LNP023) in P-ll Study for C3 Glomerulopathy at ASN Annual Meeting 2020

October 27, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us